BiotechTube
Home/Pipeline/Various Penicillin/Cephalosporin Products

Various Penicillin/Cephalosporin Products

Bacterial Infections

CommercialMarketed

Key Facts

Indication
Bacterial Infections
Phase
Commercial
Status
Marketed
Company
CSPC Pharmaceutical

About CSPC Pharmaceutical

Leading Chinese pharmaceutical company with innovative stroke drug dl-3-n-Butylphthalide advancing in US Phase 3 trials with FDA orphan drug designation.

View full company profile

Therapeutic Areas

NeurologyCardiovascularInfectious DiseaseOncology

Other Bacterial Infections Drugs

DrugCompanyPhase
Azithromycin PreparationsCSPC PharmaceuticalCommercial
Penem PreparationsCSPC PharmaceuticalCommercial
Nemonoxacin Malate CapsulesZhejiang MedicineCommercial
Generic Portfolio Expansion - Anti-infectivesAlkaloid AD SkopjeRegulatory Submission
Clindamycin Phosphate InjectionViwitCommercial
Levofloxacin Hydrochloride InjectionViwitCommercial
Meropenem-VaborbactamSciClone PharmaceuticalsCommercial (in China)
Vibativ® (telavancin)Cleo Life SciencesApproved
Penicillin V APIBiotikaCommercial
Sterile Injectable Antibiotics PortfolioSteripharmaApproved
Oral AntibioticDawah PharmaceuticalsANDA Filed/Pre-approval
XAB05/XAB06XenotheraPreclinical